Adults With IBD Show Antibody Response to mRNA COVID-19 Vaccine
After mRNA COVID-19 vaccination, 99 percent of patients with IBD had detectable antibodies regardless of immunocompromising therapies
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.